Haploids are cells or organisms containing only one complete set of chromosomes, in contrast to diploids, which have two sets. In humans, haploid cells are represented by gametes—sperm cells in males and egg cells in females. During the process of gametogenesis, specifically meiosis, a diploid cell undergoes two successive divisions to produce four haploid cells, each with a unique combination of genetic material. Haploids have significance in both sexual reproduction and genetic research. In sexual reproduction, the fusion of haploid gametes during fertilization restores the diploid chromosome number in the zygote, creating genetic diversity. In genetic research, haploid cells are valuable tools for studying gene function, as the effects of a single copy of a gene can be directly observed without interference from a second allele. The study of haploids has contributed to advancements in understanding genetics, development, and disease. Haploid cell lines have been developed for experimental purposes, aiding in the identification of essential genes and the study of gene interactions. Haploid organisms, such as certain plants and fungi, also provide unique insights into genetics and have applications in biotechnology. Overall, haploids play a fundamental role in the broader context of genetic diversity, inheritance, and scientific research.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy